Scientist Marta Ayala has just informed Cuban President Miguel Diaz-Canel that the ABDALA vaccine show 92.28% efficacy in phase III…
Cuba’s Soberana vaccine candidate has demonstrated a 62% efficacy rate in a two-dose schedule, BioCubaFarma announced on Saturday. Results are…
Cuba and Iran have signed a collaboration agreement for a joint project to carry out Phase III clinical trials of…
The president of the business group BioCubaFarma, Eduardo Martinez, announced that by the year 2021 all Cubans will be vaccinated…
While the first Cuban vaccine against COVID-19, "Soberana 01," is still in Phase II of clinical trials, the Finlay Institute…